nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—stomach cancer	0.482	0.797	CbGaD
Sulindac—PTGS2—stomach cancer	0.0647	0.107	CbGaD
Sulindac—ALB—stomach cancer	0.0577	0.0955	CbGaD
Sulindac—ALB—Irinotecan—stomach cancer	0.0175	0.271	CbGbCtD
Sulindac—ALB—Fluorouracil—stomach cancer	0.0168	0.261	CbGbCtD
Sulindac—SLC22A6—Methotrexate—stomach cancer	0.0108	0.169	CbGbCtD
Sulindac—CYP1A2—Fluorouracil—stomach cancer	0.01	0.156	CbGbCtD
Sulindac—ALB—Methotrexate—stomach cancer	0.00924	0.144	CbGbCtD
Sulindac—PTGDR2—hematopoietic system—stomach cancer	0.00467	0.0752	CbGeAlD
Sulindac—MAPK3—blood vessel—stomach cancer	0.00338	0.0544	CbGeAlD
Sulindac—AKR1B1—hematopoietic system—stomach cancer	0.00248	0.04	CbGeAlD
Sulindac—AKR1B1—epithelium—stomach cancer	0.00227	0.0365	CbGeAlD
Sulindac—AKR1B1—smooth muscle tissue—stomach cancer	0.00219	0.0352	CbGeAlD
Sulindac—AKR1B1—pancreas—stomach cancer	0.00202	0.0325	CbGeAlD
Sulindac—PPARD—hematopoietic system—stomach cancer	0.00195	0.0314	CbGeAlD
Sulindac—MAPK3—hematopoietic system—stomach cancer	0.0018	0.029	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—stomach cancer	0.00175	0.0281	CbGeAlD
Sulindac—AKR1B1—digestive system—stomach cancer	0.00173	0.0278	CbGeAlD
Sulindac—MAPK3—epithelium—stomach cancer	0.00165	0.0265	CbGeAlD
Sulindac—AKR1B1—bone marrow—stomach cancer	0.00159	0.0256	CbGeAlD
Sulindac—PPARD—pancreas—stomach cancer	0.00159	0.0256	CbGeAlD
Sulindac—MAPK3—smooth muscle tissue—stomach cancer	0.00159	0.0255	CbGeAlD
Sulindac—ALB—gall bladder—stomach cancer	0.00152	0.0244	CbGeAlD
Sulindac—MAPK3—pancreas—stomach cancer	0.00147	0.0236	CbGeAlD
Sulindac—AKR1B1—endocrine gland—stomach cancer	0.00143	0.023	CbGeAlD
Sulindac—PPARD—lymphoid tissue—stomach cancer	0.00137	0.0221	CbGeAlD
Sulindac—PPARD—digestive system—stomach cancer	0.00136	0.0219	CbGeAlD
Sulindac—AKR1B1—liver—stomach cancer	0.00129	0.0207	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—stomach cancer	0.00127	0.0204	CbGeAlD
Sulindac—MAPK3—digestive system—stomach cancer	0.00125	0.0201	CbGeAlD
Sulindac—MAPK3—bone marrow—stomach cancer	0.00115	0.0186	CbGeAlD
Sulindac—PPARD—endocrine gland—stomach cancer	0.00112	0.0181	CbGeAlD
Sulindac—MAPK3—endocrine gland—stomach cancer	0.00103	0.0166	CbGeAlD
Sulindac—PPARD—liver—stomach cancer	0.00101	0.0163	CbGeAlD
Sulindac—AKR1B1—lymph node—stomach cancer	0.000987	0.0159	CbGeAlD
Sulindac—MAPK3—liver—stomach cancer	0.000933	0.015	CbGeAlD
Sulindac—PTGS1—blood vessel—stomach cancer	0.000919	0.0148	CbGeAlD
Sulindac—PTGS2—blood vessel—stomach cancer	0.000878	0.0141	CbGeAlD
Sulindac—PTGS2—gall bladder—stomach cancer	0.000826	0.0133	CbGeAlD
Sulindac—PPARD—lymph node—stomach cancer	0.000776	0.0125	CbGeAlD
Sulindac—MAPK3—lymph node—stomach cancer	0.000715	0.0115	CbGeAlD
Sulindac—CYP1A2—hematopoietic system—stomach cancer	0.000565	0.00909	CbGeAlD
Sulindac—CYP1A1—hematopoietic system—stomach cancer	0.000557	0.00896	CbGeAlD
Sulindac—CYP1A1—epithelium—stomach cancer	0.000509	0.00819	CbGeAlD
Sulindac—PTGS1—hematopoietic system—stomach cancer	0.000489	0.00787	CbGeAlD
Sulindac—PTGS2—hematopoietic system—stomach cancer	0.000468	0.00753	CbGeAlD
Sulindac—PTGS1—epithelium—stomach cancer	0.000447	0.0072	CbGeAlD
Sulindac—ALB—liver—stomach cancer	0.000445	0.00716	CbGeAlD
Sulindac—PTGS1—smooth muscle tissue—stomach cancer	0.000431	0.00694	CbGeAlD
Sulindac—PTGS2—epithelium—stomach cancer	0.000427	0.00688	CbGeAlD
Sulindac—PTGS2—smooth muscle tissue—stomach cancer	0.000412	0.00663	CbGeAlD
Sulindac—CYP1A2—digestive system—stomach cancer	0.000393	0.00632	CbGeAlD
Sulindac—CYP1A1—digestive system—stomach cancer	0.000387	0.00623	CbGeAlD
Sulindac—PTGS2—pancreas—stomach cancer	0.000381	0.00613	CbGeAlD
Sulindac—ALB—lymph node—stomach cancer	0.000341	0.00549	CbGeAlD
Sulindac—PTGS1—digestive system—stomach cancer	0.00034	0.00548	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—stomach cancer	0.000329	0.0053	CbGeAlD
Sulindac—PTGS2—digestive system—stomach cancer	0.000325	0.00523	CbGeAlD
Sulindac—CYP1A2—endocrine gland—stomach cancer	0.000324	0.00522	CbGeAlD
Sulindac—CYP1A1—endocrine gland—stomach cancer	0.00032	0.00515	CbGeAlD
Sulindac—PTGS2—bone marrow—stomach cancer	0.0003	0.00482	CbGeAlD
Sulindac—CYP1A2—liver—stomach cancer	0.000292	0.00471	CbGeAlD
Sulindac—CYP1A1—liver—stomach cancer	0.000289	0.00464	CbGeAlD
Sulindac—PTGS1—endocrine gland—stomach cancer	0.000281	0.00452	CbGeAlD
Sulindac—PTGS2—endocrine gland—stomach cancer	0.000269	0.00432	CbGeAlD
Sulindac—PTGS2—liver—stomach cancer	0.000242	0.0039	CbGeAlD
Sulindac—CYP1A1—lymph node—stomach cancer	0.000221	0.00356	CbGeAlD
Sulindac—PTGS1—lymph node—stomach cancer	0.000194	0.00313	CbGeAlD
Sulindac—PTGS2—lymph node—stomach cancer	0.000186	0.00299	CbGeAlD
Sulindac—Haematuria—Epirubicin—stomach cancer	0.000109	0.000941	CcSEcCtD
Sulindac—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000108	0.000935	CcSEcCtD
Sulindac—Oedema—Docetaxel—stomach cancer	0.000108	0.000933	CcSEcCtD
Sulindac—Anaphylactic shock—Docetaxel—stomach cancer	0.000108	0.000933	CcSEcCtD
Sulindac—Discomfort—Capecitabine—stomach cancer	0.000108	0.000931	CcSEcCtD
Sulindac—Epistaxis—Epirubicin—stomach cancer	0.000107	0.000931	CcSEcCtD
Sulindac—Hyperglycaemia—Doxorubicin—stomach cancer	0.000107	0.000924	CcSEcCtD
Sulindac—Diarrhoea—Irinotecan—stomach cancer	0.000107	0.000924	CcSEcCtD
Sulindac—Agranulocytosis—Epirubicin—stomach cancer	0.000106	0.000921	CcSEcCtD
Sulindac—Pneumonia—Doxorubicin—stomach cancer	0.000106	0.000919	CcSEcCtD
Sulindac—Shock—Docetaxel—stomach cancer	0.000106	0.000918	CcSEcCtD
Sulindac—Pruritus—Fluorouracil—stomach cancer	0.000106	0.000915	CcSEcCtD
Sulindac—Thrombocytopenia—Docetaxel—stomach cancer	0.000106	0.000914	CcSEcCtD
Sulindac—Visual impairment—Methotrexate—stomach cancer	0.000105	0.000912	CcSEcCtD
Sulindac—Tachycardia—Docetaxel—stomach cancer	0.000105	0.000911	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000105	0.000905	CcSEcCtD
Sulindac—Oedema—Capecitabine—stomach cancer	0.000104	0.000904	CcSEcCtD
Sulindac—Renal failure—Doxorubicin—stomach cancer	0.000104	0.000898	CcSEcCtD
Sulindac—Erythema multiforme—Methotrexate—stomach cancer	0.000103	0.000895	CcSEcCtD
Sulindac—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000103	0.000895	CcSEcCtD
Sulindac—Dizziness—Irinotecan—stomach cancer	0.000103	0.000893	CcSEcCtD
Sulindac—Stomatitis—Doxorubicin—stomach cancer	0.000103	0.00089	CcSEcCtD
Sulindac—Jaundice—Doxorubicin—stomach cancer	0.000103	0.00089	CcSEcCtD
Sulindac—Anorexia—Docetaxel—stomach cancer	0.000103	0.00089	CcSEcCtD
Sulindac—Shock—Capecitabine—stomach cancer	0.000103	0.000889	CcSEcCtD
Sulindac—Conjunctivitis—Doxorubicin—stomach cancer	0.000102	0.000888	CcSEcCtD
Sulindac—Hepatitis—Epirubicin—stomach cancer	0.000102	0.000886	CcSEcCtD
Sulindac—Diarrhoea—Fluorouracil—stomach cancer	0.000102	0.000885	CcSEcCtD
Sulindac—Thrombocytopenia—Capecitabine—stomach cancer	0.000102	0.000885	CcSEcCtD
Sulindac—Tinnitus—Methotrexate—stomach cancer	0.000102	0.000883	CcSEcCtD
Sulindac—Tachycardia—Capecitabine—stomach cancer	0.000102	0.000882	CcSEcCtD
Sulindac—Sweating—Doxorubicin—stomach cancer	0.000101	0.000876	CcSEcCtD
Sulindac—Hyperhidrosis—Capecitabine—stomach cancer	0.000101	0.000874	CcSEcCtD
Sulindac—Hypotension—Docetaxel—stomach cancer	0.000101	0.000872	CcSEcCtD
Sulindac—Haematuria—Doxorubicin—stomach cancer	0.000101	0.000871	CcSEcCtD
Sulindac—Epistaxis—Doxorubicin—stomach cancer	9.95e-05	0.000861	CcSEcCtD
Sulindac—Anorexia—Capecitabine—stomach cancer	9.95e-05	0.000861	CcSEcCtD
Sulindac—Vomiting—Irinotecan—stomach cancer	9.91e-05	0.000858	CcSEcCtD
Sulindac—Dizziness—Fluorouracil—stomach cancer	9.87e-05	0.000855	CcSEcCtD
Sulindac—Visual impairment—Epirubicin—stomach cancer	9.86e-05	0.000854	CcSEcCtD
Sulindac—Agranulocytosis—Doxorubicin—stomach cancer	9.84e-05	0.000852	CcSEcCtD
Sulindac—Rash—Irinotecan—stomach cancer	9.83e-05	0.000851	CcSEcCtD
Sulindac—Dermatitis—Irinotecan—stomach cancer	9.82e-05	0.00085	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Docetaxel—stomach cancer	9.82e-05	0.00085	CcSEcCtD
Sulindac—Chills—Methotrexate—stomach cancer	9.81e-05	0.00085	CcSEcCtD
Sulindac—Headache—Irinotecan—stomach cancer	9.77e-05	0.000846	CcSEcCtD
Sulindac—Hypotension—Capecitabine—stomach cancer	9.75e-05	0.000844	CcSEcCtD
Sulindac—Insomnia—Docetaxel—stomach cancer	9.75e-05	0.000844	CcSEcCtD
Sulindac—Paraesthesia—Docetaxel—stomach cancer	9.68e-05	0.000838	CcSEcCtD
Sulindac—Erythema multiforme—Epirubicin—stomach cancer	9.67e-05	0.000838	CcSEcCtD
Sulindac—Alopecia—Methotrexate—stomach cancer	9.66e-05	0.000837	CcSEcCtD
Sulindac—Dyspnoea—Docetaxel—stomach cancer	9.61e-05	0.000832	CcSEcCtD
Sulindac—Somnolence—Docetaxel—stomach cancer	9.58e-05	0.00083	CcSEcCtD
Sulindac—Tinnitus—Epirubicin—stomach cancer	9.54e-05	0.000826	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Capecitabine—stomach cancer	9.51e-05	0.000823	CcSEcCtD
Sulindac—Flushing—Epirubicin—stomach cancer	9.49e-05	0.000822	CcSEcCtD
Sulindac—Vomiting—Fluorouracil—stomach cancer	9.49e-05	0.000822	CcSEcCtD
Sulindac—Dyspepsia—Docetaxel—stomach cancer	9.49e-05	0.000822	CcSEcCtD
Sulindac—Hepatitis—Doxorubicin—stomach cancer	9.47e-05	0.00082	CcSEcCtD
Sulindac—Insomnia—Capecitabine—stomach cancer	9.44e-05	0.000817	CcSEcCtD
Sulindac—Rash—Fluorouracil—stomach cancer	9.41e-05	0.000815	CcSEcCtD
Sulindac—Dermatitis—Fluorouracil—stomach cancer	9.4e-05	0.000815	CcSEcCtD
Sulindac—Paraesthesia—Capecitabine—stomach cancer	9.37e-05	0.000811	CcSEcCtD
Sulindac—Decreased appetite—Docetaxel—stomach cancer	9.37e-05	0.000811	CcSEcCtD
Sulindac—Headache—Fluorouracil—stomach cancer	9.35e-05	0.00081	CcSEcCtD
Sulindac—Dysgeusia—Methotrexate—stomach cancer	9.32e-05	0.000807	CcSEcCtD
Sulindac—Dyspnoea—Capecitabine—stomach cancer	9.3e-05	0.000806	CcSEcCtD
Sulindac—Fatigue—Docetaxel—stomach cancer	9.29e-05	0.000805	CcSEcCtD
Sulindac—Nausea—Irinotecan—stomach cancer	9.26e-05	0.000802	CcSEcCtD
Sulindac—Constipation—Docetaxel—stomach cancer	9.22e-05	0.000798	CcSEcCtD
Sulindac—Dyspepsia—Capecitabine—stomach cancer	9.18e-05	0.000795	CcSEcCtD
Sulindac—Chills—Epirubicin—stomach cancer	9.18e-05	0.000795	CcSEcCtD
Sulindac—Arrhythmia—Epirubicin—stomach cancer	9.14e-05	0.000792	CcSEcCtD
Sulindac—Visual impairment—Doxorubicin—stomach cancer	9.12e-05	0.00079	CcSEcCtD
Sulindac—Decreased appetite—Capecitabine—stomach cancer	9.07e-05	0.000785	CcSEcCtD
Sulindac—Alopecia—Epirubicin—stomach cancer	9.04e-05	0.000783	CcSEcCtD
Sulindac—Fatigue—Capecitabine—stomach cancer	9e-05	0.000779	CcSEcCtD
Sulindac—Vision blurred—Methotrexate—stomach cancer	8.97e-05	0.000777	CcSEcCtD
Sulindac—Erythema multiforme—Doxorubicin—stomach cancer	8.95e-05	0.000775	CcSEcCtD
Sulindac—Constipation—Capecitabine—stomach cancer	8.92e-05	0.000773	CcSEcCtD
Sulindac—Feeling abnormal—Docetaxel—stomach cancer	8.88e-05	0.000769	CcSEcCtD
Sulindac—Nausea—Fluorouracil—stomach cancer	8.87e-05	0.000768	CcSEcCtD
Sulindac—Ill-defined disorder—Methotrexate—stomach cancer	8.83e-05	0.000765	CcSEcCtD
Sulindac—Tinnitus—Doxorubicin—stomach cancer	8.83e-05	0.000764	CcSEcCtD
Sulindac—Gastrointestinal pain—Docetaxel—stomach cancer	8.81e-05	0.000763	CcSEcCtD
Sulindac—Anaemia—Methotrexate—stomach cancer	8.8e-05	0.000762	CcSEcCtD
Sulindac—Flushing—Doxorubicin—stomach cancer	8.79e-05	0.000761	CcSEcCtD
Sulindac—Flatulence—Epirubicin—stomach cancer	8.78e-05	0.00076	CcSEcCtD
Sulindac—Tension—Epirubicin—stomach cancer	8.74e-05	0.000757	CcSEcCtD
Sulindac—Dysgeusia—Epirubicin—stomach cancer	8.72e-05	0.000755	CcSEcCtD
Sulindac—Nervousness—Epirubicin—stomach cancer	8.65e-05	0.000749	CcSEcCtD
Sulindac—Feeling abnormal—Capecitabine—stomach cancer	8.6e-05	0.000745	CcSEcCtD
Sulindac—Malaise—Methotrexate—stomach cancer	8.58e-05	0.000743	CcSEcCtD
Sulindac—Vertigo—Methotrexate—stomach cancer	8.55e-05	0.00074	CcSEcCtD
Sulindac—Gastrointestinal pain—Capecitabine—stomach cancer	8.53e-05	0.000739	CcSEcCtD
Sulindac—Body temperature increased—Docetaxel—stomach cancer	8.52e-05	0.000738	CcSEcCtD
Sulindac—Leukopenia—Methotrexate—stomach cancer	8.52e-05	0.000738	CcSEcCtD
Sulindac—Chills—Doxorubicin—stomach cancer	8.49e-05	0.000736	CcSEcCtD
Sulindac—Arrhythmia—Doxorubicin—stomach cancer	8.46e-05	0.000732	CcSEcCtD
Sulindac—Vision blurred—Epirubicin—stomach cancer	8.39e-05	0.000727	CcSEcCtD
Sulindac—Alopecia—Doxorubicin—stomach cancer	8.36e-05	0.000724	CcSEcCtD
Sulindac—Urticaria—Capecitabine—stomach cancer	8.29e-05	0.000718	CcSEcCtD
Sulindac—Ill-defined disorder—Epirubicin—stomach cancer	8.26e-05	0.000716	CcSEcCtD
Sulindac—Body temperature increased—Capecitabine—stomach cancer	8.25e-05	0.000714	CcSEcCtD
Sulindac—Convulsion—Methotrexate—stomach cancer	8.25e-05	0.000714	CcSEcCtD
Sulindac—Anaemia—Epirubicin—stomach cancer	8.23e-05	0.000713	CcSEcCtD
Sulindac—Flatulence—Doxorubicin—stomach cancer	8.12e-05	0.000703	CcSEcCtD
Sulindac—Arthralgia—Methotrexate—stomach cancer	8.1e-05	0.000702	CcSEcCtD
Sulindac—Myalgia—Methotrexate—stomach cancer	8.1e-05	0.000702	CcSEcCtD
Sulindac—Chest pain—Methotrexate—stomach cancer	8.1e-05	0.000702	CcSEcCtD
Sulindac—Tension—Doxorubicin—stomach cancer	8.09e-05	0.0007	CcSEcCtD
Sulindac—Dysgeusia—Doxorubicin—stomach cancer	8.07e-05	0.000699	CcSEcCtD
Sulindac—Malaise—Epirubicin—stomach cancer	8.03e-05	0.000696	CcSEcCtD
Sulindac—Discomfort—Methotrexate—stomach cancer	8e-05	0.000693	CcSEcCtD
Sulindac—Nervousness—Doxorubicin—stomach cancer	8e-05	0.000693	CcSEcCtD
Sulindac—Vertigo—Epirubicin—stomach cancer	8e-05	0.000693	CcSEcCtD
Sulindac—Syncope—Epirubicin—stomach cancer	7.99e-05	0.000692	CcSEcCtD
Sulindac—Leukopenia—Epirubicin—stomach cancer	7.97e-05	0.00069	CcSEcCtD
Sulindac—Hypersensitivity—Docetaxel—stomach cancer	7.94e-05	0.000688	CcSEcCtD
Sulindac—Palpitations—Epirubicin—stomach cancer	7.87e-05	0.000682	CcSEcCtD
Sulindac—Loss of consciousness—Epirubicin—stomach cancer	7.83e-05	0.000678	CcSEcCtD
Sulindac—Anaphylactic shock—Methotrexate—stomach cancer	7.77e-05	0.000673	CcSEcCtD
Sulindac—Vision blurred—Doxorubicin—stomach cancer	7.77e-05	0.000673	CcSEcCtD
Sulindac—Asthenia—Docetaxel—stomach cancer	7.73e-05	0.00067	CcSEcCtD
Sulindac—Convulsion—Epirubicin—stomach cancer	7.72e-05	0.000668	CcSEcCtD
Sulindac—Hypertension—Epirubicin—stomach cancer	7.69e-05	0.000666	CcSEcCtD
Sulindac—Hypersensitivity—Capecitabine—stomach cancer	7.69e-05	0.000666	CcSEcCtD
Sulindac—Ill-defined disorder—Doxorubicin—stomach cancer	7.65e-05	0.000662	CcSEcCtD
Sulindac—Pruritus—Docetaxel—stomach cancer	7.62e-05	0.00066	CcSEcCtD
Sulindac—Anaemia—Doxorubicin—stomach cancer	7.62e-05	0.00066	CcSEcCtD
Sulindac—Thrombocytopenia—Methotrexate—stomach cancer	7.6e-05	0.000659	CcSEcCtD
Sulindac—Myalgia—Epirubicin—stomach cancer	7.58e-05	0.000657	CcSEcCtD
Sulindac—Chest pain—Epirubicin—stomach cancer	7.58e-05	0.000657	CcSEcCtD
Sulindac—Arthralgia—Epirubicin—stomach cancer	7.58e-05	0.000657	CcSEcCtD
Sulindac—Hyperhidrosis—Methotrexate—stomach cancer	7.51e-05	0.00065	CcSEcCtD
Sulindac—Discomfort—Epirubicin—stomach cancer	7.49e-05	0.000649	CcSEcCtD
Sulindac—Asthenia—Capecitabine—stomach cancer	7.49e-05	0.000648	CcSEcCtD
Sulindac—Malaise—Doxorubicin—stomach cancer	7.43e-05	0.000644	CcSEcCtD
Sulindac—Vertigo—Doxorubicin—stomach cancer	7.4e-05	0.000641	CcSEcCtD
Sulindac—Anorexia—Methotrexate—stomach cancer	7.4e-05	0.000641	CcSEcCtD
Sulindac—Syncope—Doxorubicin—stomach cancer	7.39e-05	0.00064	CcSEcCtD
Sulindac—Pruritus—Capecitabine—stomach cancer	7.38e-05	0.000639	CcSEcCtD
Sulindac—Leukopenia—Doxorubicin—stomach cancer	7.38e-05	0.000639	CcSEcCtD
Sulindac—Diarrhoea—Docetaxel—stomach cancer	7.37e-05	0.000639	CcSEcCtD
Sulindac—Palpitations—Doxorubicin—stomach cancer	7.28e-05	0.000631	CcSEcCtD
Sulindac—Anaphylactic shock—Epirubicin—stomach cancer	7.27e-05	0.000629	CcSEcCtD
Sulindac—Oedema—Epirubicin—stomach cancer	7.27e-05	0.000629	CcSEcCtD
Sulindac—Hypotension—Methotrexate—stomach cancer	7.26e-05	0.000629	CcSEcCtD
Sulindac—Loss of consciousness—Doxorubicin—stomach cancer	7.24e-05	0.000627	CcSEcCtD
Sulindac—Shock—Epirubicin—stomach cancer	7.15e-05	0.000619	CcSEcCtD
Sulindac—Convulsion—Doxorubicin—stomach cancer	7.14e-05	0.000618	CcSEcCtD
Sulindac—Diarrhoea—Capecitabine—stomach cancer	7.14e-05	0.000618	CcSEcCtD
Sulindac—Dizziness—Docetaxel—stomach cancer	7.13e-05	0.000617	CcSEcCtD
Sulindac—Thrombocytopenia—Epirubicin—stomach cancer	7.12e-05	0.000616	CcSEcCtD
Sulindac—Hypertension—Doxorubicin—stomach cancer	7.11e-05	0.000616	CcSEcCtD
Sulindac—Tachycardia—Epirubicin—stomach cancer	7.09e-05	0.000614	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.08e-05	0.000613	CcSEcCtD
Sulindac—Hyperhidrosis—Epirubicin—stomach cancer	7.03e-05	0.000609	CcSEcCtD
Sulindac—Insomnia—Methotrexate—stomach cancer	7.02e-05	0.000608	CcSEcCtD
Sulindac—Arthralgia—Doxorubicin—stomach cancer	7.02e-05	0.000608	CcSEcCtD
Sulindac—Chest pain—Doxorubicin—stomach cancer	7.02e-05	0.000608	CcSEcCtD
Sulindac—Myalgia—Doxorubicin—stomach cancer	7.02e-05	0.000608	CcSEcCtD
Sulindac—Paraesthesia—Methotrexate—stomach cancer	6.97e-05	0.000604	CcSEcCtD
Sulindac—Discomfort—Doxorubicin—stomach cancer	6.93e-05	0.0006	CcSEcCtD
Sulindac—Anorexia—Epirubicin—stomach cancer	6.93e-05	0.0006	CcSEcCtD
Sulindac—Dyspnoea—Methotrexate—stomach cancer	6.92e-05	0.0006	CcSEcCtD
Sulindac—Somnolence—Methotrexate—stomach cancer	6.9e-05	0.000598	CcSEcCtD
Sulindac—Dizziness—Capecitabine—stomach cancer	6.9e-05	0.000598	CcSEcCtD
Sulindac—Vomiting—Docetaxel—stomach cancer	6.85e-05	0.000593	CcSEcCtD
Sulindac—Dyspepsia—Methotrexate—stomach cancer	6.84e-05	0.000592	CcSEcCtD
Sulindac—Rash—Docetaxel—stomach cancer	6.79e-05	0.000588	CcSEcCtD
Sulindac—Hypotension—Epirubicin—stomach cancer	6.79e-05	0.000588	CcSEcCtD
Sulindac—Dermatitis—Docetaxel—stomach cancer	6.79e-05	0.000588	CcSEcCtD
Sulindac—Decreased appetite—Methotrexate—stomach cancer	6.75e-05	0.000585	CcSEcCtD
Sulindac—Headache—Docetaxel—stomach cancer	6.75e-05	0.000585	CcSEcCtD
Sulindac—Oedema—Doxorubicin—stomach cancer	6.73e-05	0.000582	CcSEcCtD
Sulindac—Anaphylactic shock—Doxorubicin—stomach cancer	6.73e-05	0.000582	CcSEcCtD
Sulindac—Fatigue—Methotrexate—stomach cancer	6.7e-05	0.00058	CcSEcCtD
Sulindac—Vomiting—Capecitabine—stomach cancer	6.63e-05	0.000575	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.62e-05	0.000574	CcSEcCtD
Sulindac—Shock—Doxorubicin—stomach cancer	6.62e-05	0.000573	CcSEcCtD
Sulindac—Thrombocytopenia—Doxorubicin—stomach cancer	6.58e-05	0.00057	CcSEcCtD
Sulindac—Rash—Capecitabine—stomach cancer	6.58e-05	0.00057	CcSEcCtD
Sulindac—Insomnia—Epirubicin—stomach cancer	6.57e-05	0.000569	CcSEcCtD
Sulindac—Dermatitis—Capecitabine—stomach cancer	6.57e-05	0.000569	CcSEcCtD
Sulindac—Tachycardia—Doxorubicin—stomach cancer	6.56e-05	0.000568	CcSEcCtD
Sulindac—Headache—Capecitabine—stomach cancer	6.54e-05	0.000566	CcSEcCtD
Sulindac—Paraesthesia—Epirubicin—stomach cancer	6.53e-05	0.000565	CcSEcCtD
Sulindac—Hyperhidrosis—Doxorubicin—stomach cancer	6.5e-05	0.000563	CcSEcCtD
Sulindac—Dyspnoea—Epirubicin—stomach cancer	6.48e-05	0.000561	CcSEcCtD
Sulindac—Somnolence—Epirubicin—stomach cancer	6.46e-05	0.00056	CcSEcCtD
Sulindac—Anorexia—Doxorubicin—stomach cancer	6.41e-05	0.000555	CcSEcCtD
Sulindac—Nausea—Docetaxel—stomach cancer	6.4e-05	0.000554	CcSEcCtD
Sulindac—Feeling abnormal—Methotrexate—stomach cancer	6.4e-05	0.000554	CcSEcCtD
Sulindac—Dyspepsia—Epirubicin—stomach cancer	6.4e-05	0.000554	CcSEcCtD
Sulindac—Gastrointestinal pain—Methotrexate—stomach cancer	6.35e-05	0.00055	CcSEcCtD
Sulindac—Decreased appetite—Epirubicin—stomach cancer	6.32e-05	0.000547	CcSEcCtD
Sulindac—Hypotension—Doxorubicin—stomach cancer	6.28e-05	0.000544	CcSEcCtD
Sulindac—Fatigue—Epirubicin—stomach cancer	6.27e-05	0.000543	CcSEcCtD
Sulindac—Constipation—Epirubicin—stomach cancer	6.22e-05	0.000538	CcSEcCtD
Sulindac—Nausea—Capecitabine—stomach cancer	6.2e-05	0.000537	CcSEcCtD
Sulindac—Urticaria—Methotrexate—stomach cancer	6.17e-05	0.000534	CcSEcCtD
Sulindac—Body temperature increased—Methotrexate—stomach cancer	6.14e-05	0.000532	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.13e-05	0.000531	CcSEcCtD
Sulindac—Insomnia—Doxorubicin—stomach cancer	6.08e-05	0.000527	CcSEcCtD
Sulindac—Paraesthesia—Doxorubicin—stomach cancer	6.04e-05	0.000523	CcSEcCtD
Sulindac—Dyspnoea—Doxorubicin—stomach cancer	6e-05	0.000519	CcSEcCtD
Sulindac—Feeling abnormal—Epirubicin—stomach cancer	5.99e-05	0.000519	CcSEcCtD
Sulindac—Somnolence—Doxorubicin—stomach cancer	5.98e-05	0.000518	CcSEcCtD
Sulindac—Gastrointestinal pain—Epirubicin—stomach cancer	5.94e-05	0.000515	CcSEcCtD
Sulindac—Dyspepsia—Doxorubicin—stomach cancer	5.92e-05	0.000513	CcSEcCtD
Sulindac—Decreased appetite—Doxorubicin—stomach cancer	5.85e-05	0.000506	CcSEcCtD
Sulindac—Fatigue—Doxorubicin—stomach cancer	5.8e-05	0.000502	CcSEcCtD
Sulindac—Urticaria—Epirubicin—stomach cancer	5.77e-05	0.0005	CcSEcCtD
Sulindac—Constipation—Doxorubicin—stomach cancer	5.75e-05	0.000498	CcSEcCtD
Sulindac—Body temperature increased—Epirubicin—stomach cancer	5.75e-05	0.000498	CcSEcCtD
Sulindac—Hypersensitivity—Methotrexate—stomach cancer	5.72e-05	0.000496	CcSEcCtD
Sulindac—Asthenia—Methotrexate—stomach cancer	5.57e-05	0.000483	CcSEcCtD
Sulindac—Feeling abnormal—Doxorubicin—stomach cancer	5.54e-05	0.00048	CcSEcCtD
Sulindac—Gastrointestinal pain—Doxorubicin—stomach cancer	5.5e-05	0.000476	CcSEcCtD
Sulindac—Pruritus—Methotrexate—stomach cancer	5.49e-05	0.000476	CcSEcCtD
Sulindac—Hypersensitivity—Epirubicin—stomach cancer	5.36e-05	0.000464	CcSEcCtD
Sulindac—Urticaria—Doxorubicin—stomach cancer	5.34e-05	0.000463	CcSEcCtD
Sulindac—Body temperature increased—Doxorubicin—stomach cancer	5.32e-05	0.00046	CcSEcCtD
Sulindac—Diarrhoea—Methotrexate—stomach cancer	5.31e-05	0.00046	CcSEcCtD
Sulindac—Asthenia—Epirubicin—stomach cancer	5.21e-05	0.000452	CcSEcCtD
Sulindac—Pruritus—Epirubicin—stomach cancer	5.14e-05	0.000445	CcSEcCtD
Sulindac—Dizziness—Methotrexate—stomach cancer	5.14e-05	0.000445	CcSEcCtD
Sulindac—Diarrhoea—Epirubicin—stomach cancer	4.97e-05	0.000431	CcSEcCtD
Sulindac—Hypersensitivity—Doxorubicin—stomach cancer	4.95e-05	0.000429	CcSEcCtD
Sulindac—Vomiting—Methotrexate—stomach cancer	4.94e-05	0.000428	CcSEcCtD
Sulindac—Rash—Methotrexate—stomach cancer	4.9e-05	0.000424	CcSEcCtD
Sulindac—Dermatitis—Methotrexate—stomach cancer	4.89e-05	0.000424	CcSEcCtD
Sulindac—Headache—Methotrexate—stomach cancer	4.87e-05	0.000421	CcSEcCtD
Sulindac—Asthenia—Doxorubicin—stomach cancer	4.83e-05	0.000418	CcSEcCtD
Sulindac—Dizziness—Epirubicin—stomach cancer	4.81e-05	0.000416	CcSEcCtD
Sulindac—Pruritus—Doxorubicin—stomach cancer	4.76e-05	0.000412	CcSEcCtD
Sulindac—Vomiting—Epirubicin—stomach cancer	4.62e-05	0.0004	CcSEcCtD
Sulindac—Nausea—Methotrexate—stomach cancer	4.61e-05	0.0004	CcSEcCtD
Sulindac—Diarrhoea—Doxorubicin—stomach cancer	4.6e-05	0.000399	CcSEcCtD
Sulindac—Rash—Epirubicin—stomach cancer	4.58e-05	0.000397	CcSEcCtD
Sulindac—Dermatitis—Epirubicin—stomach cancer	4.58e-05	0.000397	CcSEcCtD
Sulindac—Headache—Epirubicin—stomach cancer	4.55e-05	0.000394	CcSEcCtD
Sulindac—Dizziness—Doxorubicin—stomach cancer	4.45e-05	0.000385	CcSEcCtD
Sulindac—Nausea—Epirubicin—stomach cancer	4.32e-05	0.000374	CcSEcCtD
Sulindac—Vomiting—Doxorubicin—stomach cancer	4.28e-05	0.00037	CcSEcCtD
Sulindac—Rash—Doxorubicin—stomach cancer	4.24e-05	0.000367	CcSEcCtD
Sulindac—Dermatitis—Doxorubicin—stomach cancer	4.24e-05	0.000367	CcSEcCtD
Sulindac—Headache—Doxorubicin—stomach cancer	4.21e-05	0.000365	CcSEcCtD
Sulindac—Nausea—Doxorubicin—stomach cancer	3.99e-05	0.000346	CcSEcCtD
Sulindac—MAPK3—Disease—IL6ST—stomach cancer	5.91e-06	3.84e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARG—stomach cancer	5.9e-06	3.83e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PRKCB—stomach cancer	5.9e-06	3.83e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	5.89e-06	3.83e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALDH7A1—stomach cancer	5.76e-06	3.74e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLCE1—stomach cancer	5.76e-06	3.74e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKR1C3—stomach cancer	5.75e-06	3.73e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—stomach cancer	5.73e-06	3.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CASP8—stomach cancer	5.73e-06	3.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6R—stomach cancer	5.71e-06	3.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MAPK1—stomach cancer	5.69e-06	3.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—stomach cancer	5.68e-06	3.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—APC—stomach cancer	5.68e-06	3.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDH1—stomach cancer	5.66e-06	3.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RHOA—stomach cancer	5.65e-06	3.67e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.64e-06	3.66e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.63e-06	3.65e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ENO1—stomach cancer	5.6e-06	3.64e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HBEGF—stomach cancer	5.58e-06	3.62e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ALOX5—stomach cancer	5.56e-06	3.61e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—UMPS—stomach cancer	5.52e-06	3.58e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SMAD4—stomach cancer	5.52e-06	3.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.51e-06	3.58e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PIK3CA—stomach cancer	5.48e-06	3.56e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—DPYD—stomach cancer	5.47e-06	3.55e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.44e-06	3.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—KRAS—stomach cancer	5.37e-06	3.49e-05	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	5.35e-06	3.47e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPP2R1A—stomach cancer	5.32e-06	3.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SERPINE1—stomach cancer	5.32e-06	3.45e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTT1—stomach cancer	5.31e-06	3.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—stomach cancer	5.3e-06	3.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6R—stomach cancer	5.27e-06	3.42e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2A6—stomach cancer	5.25e-06	3.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FYN—stomach cancer	5.24e-06	3.4e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTP1—stomach cancer	5.22e-06	3.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HRAS—stomach cancer	5.17e-06	3.36e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HMOX1—stomach cancer	5.15e-06	3.34e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PDHA1—stomach cancer	5.13e-06	3.33e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ECHS1—stomach cancer	5.13e-06	3.33e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	5.12e-06	3.32e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKR1C3—stomach cancer	5.1e-06	3.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—HRAS—stomach cancer	5.07e-06	3.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PPP2R1A—stomach cancer	5.05e-06	3.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—stomach cancer	5e-06	3.25e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ENO1—stomach cancer	4.97e-06	3.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD44—stomach cancer	4.97e-06	3.23e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.96e-06	3.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—stomach cancer	4.96e-06	3.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—stomach cancer	4.95e-06	3.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—SERPINE1—stomach cancer	4.94e-06	3.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—PIK3CA—stomach cancer	4.93e-06	3.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR2—stomach cancer	4.92e-06	3.19e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SERPINE1—stomach cancer	4.91e-06	3.19e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.89e-06	3.18e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TYMS—stomach cancer	4.85e-06	3.15e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTT1—stomach cancer	4.84e-06	3.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TYMP—stomach cancer	4.83e-06	3.13e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—FADS1—stomach cancer	4.83e-06	3.13e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTM1—stomach cancer	4.8e-06	3.12e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2A6—stomach cancer	4.78e-06	3.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB2—stomach cancer	4.78e-06	3.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—RHOA—stomach cancer	4.76e-06	3.09e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—RHOA—stomach cancer	4.73e-06	3.07e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—stomach cancer	4.71e-06	3.06e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SMAD4—stomach cancer	4.69e-06	3.04e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—stomach cancer	4.69e-06	3.04e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKR1C3—stomach cancer	4.65e-06	3.02e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—HRAS—stomach cancer	4.56e-06	2.96e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ENO1—stomach cancer	4.53e-06	2.94e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SREBF2—stomach cancer	4.52e-06	2.93e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ERCC2—stomach cancer	4.51e-06	2.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IRS2—stomach cancer	4.5e-06	2.92e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—RORA—stomach cancer	4.47e-06	2.9e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—FYN—stomach cancer	4.45e-06	2.89e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDKN1B—stomach cancer	4.42e-06	2.87e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD44—stomach cancer	4.41e-06	2.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB2—stomach cancer	4.41e-06	2.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—stomach cancer	4.37e-06	2.84e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CAV1—stomach cancer	4.37e-06	2.83e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOA1—stomach cancer	4.36e-06	2.83e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PIK3CA—stomach cancer	4.35e-06	2.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—stomach cancer	4.35e-06	2.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—stomach cancer	4.31e-06	2.8e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.28e-06	2.78e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERCC2—stomach cancer	4.28e-06	2.78e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—stomach cancer	4.24e-06	2.75e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPP2R1A—stomach cancer	4.23e-06	2.74e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—JUN—stomach cancer	4.21e-06	2.73e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALDOB—stomach cancer	4.18e-06	2.72e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR2—stomach cancer	4.18e-06	2.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRKCB—stomach cancer	4.16e-06	2.7e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTP1—stomach cancer	4.15e-06	2.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6ST—stomach cancer	4.14e-06	2.69e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—stomach cancer	4.09e-06	2.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CDKN1B—stomach cancer	4.08e-06	2.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDKN1A—stomach cancer	4.08e-06	2.65e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD44—stomach cancer	4.02e-06	2.61e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—stomach cancer	4.02e-06	2.61e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK8—stomach cancer	3.98e-06	2.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APC—stomach cancer	3.98e-06	2.58e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.95e-06	2.56e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.94e-06	2.56e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CAV1—stomach cancer	3.91e-06	2.54e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOA1—stomach cancer	3.9e-06	2.53e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.9e-06	2.53e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALOX5—stomach cancer	3.89e-06	2.53e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TYMS—stomach cancer	3.85e-06	2.5e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DPYD—stomach cancer	3.83e-06	2.48e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS2—stomach cancer	3.82e-06	2.48e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTM1—stomach cancer	3.81e-06	2.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CDKN1A—stomach cancer	3.77e-06	2.45e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPP2R1A—stomach cancer	3.75e-06	2.43e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.74e-06	2.43e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CAV1—stomach cancer	3.71e-06	2.41e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOA1—stomach cancer	3.7e-06	2.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6R—stomach cancer	3.69e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTP1—stomach cancer	3.68e-06	2.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—stomach cancer	3.64e-06	2.36e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—stomach cancer	3.63e-06	2.36e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—MAPK1—stomach cancer	3.62e-06	2.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—stomach cancer	3.62e-06	2.35e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ERCC2—stomach cancer	3.58e-06	2.33e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6ST—stomach cancer	3.52e-06	2.28e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.47e-06	2.25e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—stomach cancer	3.46e-06	2.24e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—stomach cancer	3.44e-06	2.23e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—KRAS—stomach cancer	3.42e-06	2.22e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TYMS—stomach cancer	3.42e-06	2.22e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPP2R1A—stomach cancer	3.42e-06	2.22e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTT1—stomach cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTM1—stomach cancer	3.38e-06	2.19e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APC—stomach cancer	3.38e-06	2.19e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—stomach cancer	3.38e-06	2.19e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—stomach cancer	3.37e-06	2.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MYC—stomach cancer	3.37e-06	2.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—stomach cancer	3.36e-06	2.18e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTP1—stomach cancer	3.35e-06	2.18e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2A6—stomach cancer	3.35e-06	2.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RHOA—stomach cancer	3.34e-06	2.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK1—stomach cancer	3.31e-06	2.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—stomach cancer	3.31e-06	2.15e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—stomach cancer	3.31e-06	2.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—stomach cancer	3.3e-06	2.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKR1C3—stomach cancer	3.25e-06	2.11e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MAPK3—stomach cancer	3.19e-06	2.07e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ERCC2—stomach cancer	3.18e-06	2.06e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ENO1—stomach cancer	3.17e-06	2.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PIK3CA—stomach cancer	3.15e-06	2.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6R—stomach cancer	3.14e-06	2.04e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KRAS—stomach cancer	3.13e-06	2.03e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—MYC—stomach cancer	3.13e-06	2.03e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.12e-06	2.02e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—TYMS—stomach cancer	3.12e-06	2.02e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAV1—stomach cancer	3.11e-06	2.02e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOA1—stomach cancer	3.1e-06	2.01e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—stomach cancer	3.09e-06	2.01e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB2—stomach cancer	3.09e-06	2e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTM1—stomach cancer	3.08e-06	2e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—MAPK1—stomach cancer	3.06e-06	1.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—stomach cancer	3.06e-06	1.98e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MAPK1—stomach cancer	3.04e-06	1.97e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—stomach cancer	2.99e-06	1.94e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.97e-06	1.93e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—stomach cancer	2.96e-06	1.92e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—stomach cancer	2.94e-06	1.91e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—stomach cancer	2.93e-06	1.9e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HRAS—stomach cancer	2.91e-06	1.89e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ERCC2—stomach cancer	2.9e-06	1.88e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—KRAS—stomach cancer	2.89e-06	1.87e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PIK3CA—stomach cancer	2.87e-06	1.87e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—KRAS—stomach cancer	2.87e-06	1.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CDKN1B—stomach cancer	2.86e-06	1.86e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—RHOA—stomach cancer	2.83e-06	1.84e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD44—stomach cancer	2.81e-06	1.83e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—stomach cancer	2.8e-06	1.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—stomach cancer	2.78e-06	1.81e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAV1—stomach cancer	2.76e-06	1.79e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOA1—stomach cancer	2.75e-06	1.79e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—stomach cancer	2.73e-06	1.77e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.73e-06	1.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCND1—stomach cancer	2.73e-06	1.77e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—stomach cancer	2.72e-06	1.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JUN—stomach cancer	2.72e-06	1.77e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—stomach cancer	2.71e-06	1.76e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HRAS—stomach cancer	2.66e-06	1.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PIK3CA—stomach cancer	2.65e-06	1.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—stomach cancer	2.65e-06	1.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CDKN1A—stomach cancer	2.64e-06	1.71e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PIK3CA—stomach cancer	2.64e-06	1.71e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.63e-06	1.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB2—stomach cancer	2.62e-06	1.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK8—stomach cancer	2.58e-06	1.67e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—stomach cancer	2.55e-06	1.66e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—stomach cancer	2.54e-06	1.65e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAV1—stomach cancer	2.51e-06	1.63e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOA1—stomach cancer	2.51e-06	1.63e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—stomach cancer	2.45e-06	1.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—HRAS—stomach cancer	2.45e-06	1.59e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HRAS—stomach cancer	2.44e-06	1.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CDKN1B—stomach cancer	2.43e-06	1.58e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—stomach cancer	2.42e-06	1.57e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.4e-06	1.56e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.39e-06	1.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—stomach cancer	2.38e-06	1.54e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—stomach cancer	2.36e-06	1.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—stomach cancer	2.35e-06	1.53e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—stomach cancer	2.35e-06	1.52e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTP1—stomach cancer	2.35e-06	1.52e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—stomach cancer	2.31e-06	1.5e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CDKN1A—stomach cancer	2.24e-06	1.46e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—stomach cancer	2.21e-06	1.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MYC—stomach cancer	2.19e-06	1.42e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TYMS—stomach cancer	2.18e-06	1.42e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—stomach cancer	2.18e-06	1.41e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTM1—stomach cancer	2.16e-06	1.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK1—stomach cancer	2.14e-06	1.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—stomach cancer	2.14e-06	1.39e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—stomach cancer	2.08e-06	1.35e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ERCC2—stomach cancer	2.03e-06	1.32e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KRAS—stomach cancer	2.02e-06	1.31e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—stomach cancer	2e-06	1.3e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAPK3—stomach cancer	1.91e-06	1.24e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—stomach cancer	1.91e-06	1.24e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—stomach cancer	1.91e-06	1.24e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—stomach cancer	1.9e-06	1.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MYC—stomach cancer	1.86e-06	1.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CA—stomach cancer	1.86e-06	1.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAPK1—stomach cancer	1.82e-06	1.18e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—stomach cancer	1.82e-06	1.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—stomach cancer	1.8e-06	1.17e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAV1—stomach cancer	1.76e-06	1.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA1—stomach cancer	1.75e-06	1.14e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—stomach cancer	1.74e-06	1.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HRAS—stomach cancer	1.72e-06	1.12e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—KRAS—stomach cancer	1.72e-06	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.68e-06	1.09e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CA—stomach cancer	1.66e-06	1.08e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—stomach cancer	1.65e-06	1.07e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3CA—stomach cancer	1.58e-06	1.02e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—stomach cancer	1.54e-06	1e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HRAS—stomach cancer	1.46e-06	9.48e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—stomach cancer	1.4e-06	9.07e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—stomach cancer	1.39e-06	9.02e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—stomach cancer	1.33e-06	8.63e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CA—stomach cancer	1.32e-06	8.58e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—stomach cancer	1.22e-06	7.89e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.17e-06	7.61e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CA—stomach cancer	1.07e-06	6.94e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CA—stomach cancer	7.48e-07	4.85e-06	CbGpPWpGaD
